BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang L, Mmagu O, Liu L, Li D, Fan Y, Baranchuk A, Kowey PR. Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients? World J Cardiol 2014; 6(8): 764-770 [PMID: 25228955 DOI: 10.4330/wjc.v6.i8.764]
URL: https://www.wjgnet.com/1949-8462/full/v6/i8/764.htm
Number Citing Articles
1
Efstathios D. Pagourelias, Georgios M. Alexandridis, Vassilios P. Vassilikos. Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessmentHeart Failure Reviews 2021; 26(6): 1297 doi: 10.1007/s10741-020-10058-6
2
Masato Shimizu, Mitsuhiro Nishizaki. Biomarkers in Cardiovascular Disease2015; : 1 doi: 10.1007/978-94-007-7741-5_26-1
3
Axel Sarrias, Enrique Galve, Xavier Sabaté, Roger Villuendas. La importancia de la estratificación de riesgo de muerte súbita en la miocardiopatía hipertrófica. RespuestaRevista Española de Cardiología 2015; 68(6): 545 doi: 10.1016/j.recesp.2015.02.007
4
Masato Shimizu, Mitsuhiro Nishizaki. Biomarkers in Cardiovascular Disease2016; : 1135 doi: 10.1007/978-94-007-7678-4_26
5
Minjie Lu, Hui Du, Zhan Gao, Lei Song, Huaibing Cheng, Yan Zhang, Gang Yin, Xiuyu Chen, Jian Ling, Yong Jiang, Hao Wang, Jinghui Li, Jinghan Huang, Zuoxiang He, Shihua Zhao. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive CardiomyopathyCirculation: Cardiovascular Interventions 2016; 9(3) doi: 10.1161/CIRCINTERVENTIONS.115.002675
6
Dunia Bárbara Benítez Ramos, Michel Cabrera Ortega, Jesús Castro Hevia, Margarita Dorantes Sánchez, Ailema Amelia Alemán Fernández, Osmin Castañeda Chirino, Marlenis Cruz Cardentey, Frank Martínez López, Roylan Falcón Rodríguez. Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart DiseasesPediatric Cardiology 2017; 38(8): 1663 doi: 10.1007/s00246-017-1711-9
7
Karine Guerrier, Peace C Madueme, John L Jefferies, Jeffrey B Anderson, David S Spar, Timothy K Knilans, Richard J Czosek. Unexpectedly low left ventricular voltage on ECG in hypertrophic cardiomyopathyHeart 2016; 102(4): 292 doi: 10.1136/heartjnl-2015-308633
8
Andrés Ricardo Pérez-Riera, Raimundo Barbosa-Barros, Mohammad Shenasa. Electrocardiographic Markers of Sudden Cardiac Death (Including Left Ventricular Hypertrophy)Cardiac Electrophysiology Clinics 2017; 9(4): 605 doi: 10.1016/j.ccep.2017.07.011
9
Loren Joseph, Milena Cankovic, Samuel Caughron, Pranil Chandra, Rajyasree Emmadi, Jill Hagenkord, Stephanie Hallam, Kay E. Jewell, Roger D. Klein, Victoria M. Pratt, Paul G. Rothberg, Robyn L. Temple-Smolkin, Elaine Lyon. The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and CancerThe Journal of Molecular Diagnostics 2016; 18(5): 605 doi: 10.1016/j.jmoldx.2016.05.007
10
Guoliang Wang, Ruirui Ji, Wenxin Zou, Daniel J. Penny, Yuxin Fan. Inherited Cardiomyopathies: Genetics and Clinical Genetic TestingCardiovascular Innovations and Applications 2017; 2(2) doi: 10.15212/CVIA.2017.0015
11
Clinical Arrhythmology2017; : 165 doi: 10.1002/9781119212782.ch5
12
Clinical Arrhythmology2017; : 273 doi: 10.1002/9781119212782.ch9
13
Axel Sarrias, Enrique Galve, Xavier Sabaté, Roger Villuendas. Importance of Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy. ResponseRevista Española de Cardiología (English Edition) 2015; 68(6): 545 doi: 10.1016/j.rec.2015.02.007
14
Guoliang Wang, Vivan Niewiadonski, Jianping Li, Ruirui Ji, Wenxin Zou, Daniel J. Penny, Yuxin Fan. Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders2017; : 243 doi: 10.1007/978-3-319-56418-0_12
15
Clinical Electrocardiography2021; : 478 doi: 10.1002/9781119536475.ch21